Atlas Trials

Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC

Clinical trial NCT02315755 · COMPLETED

Trial details

NCT number
NCT02315755
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Renal Cell Carcinoma
Start date
2015-05-11
Primary completion
2017-11-20
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.